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Abstract
Carbapenem-resistant Klebsiella pneumoniae (CRKP) increasingly cause high-mortality outbreaks in hospital settings globally.
Following a patient fatality at a hospital in Beijing due to a blaKPC-2-positive CRKP infection, close monitoring was put in place
over the course of 14months to characterize all blaKPC-2-positive CRKP in circulation in the hospital. Whole genome
sequences were generated for 100 isolates from blaKPC-2-positive isolates from infected patients, carriers and the hospital
environment. Phylogenetic analyses identified a closely related cluster of 82 sequence type 11 (ST11) isolates circulating in
the hospital for at least a year prior to admission of the index patient. The majority of inferred transmissions for these
isolates involved patients in intensive care units. Whilst the 82 ST11 isolates collected during the surveillance effort all had
closely related chromosomes, we observed extensive diversity in their antimicrobial resistance (AMR) phenotypes. We were
able to reconstruct the major genomic changes underpinning this variation in AMR profiles, including multiple gains and
losses of entire plasmids and recombination events between plasmids, including transposition of blaKPC-2. We also identified
specific cases where variation in plasmid copy number correlated with the level of phenotypic resistance to drugs,
suggesting that the number of resistance elements carried by a strain may play a role in determining the level of AMR. Our
findings highlight the epidemiological value of whole genome sequencing for investigating multi-drug-resistant hospital
infections and illustrate that standard typing schemes cannot capture the extraordinarily fast genome evolution of CRKP
isolates.
DATA SUMMARY
Raw Illumina short-read and PacBio long-read sequences
have been deposited on NCBI with BioProject ID
PRJNA508760. Full accompanying metadata and pheno-
typic resistance characterization are available in Tables
S1 and S2 (available in the online version of this article). All
programs used in bioinformatics analyses are publicly
available.
INTRODUCTION
The increasing incidence of antimicrobial resistance (AMR)
in nosocomial bacteria poses a growing threat to patient pop-
ulations in hospitals worldwide. The genetic basis underlying
AMR phenotypes varies depending on the therapeutic drug
class, resistance mechanism and organism. Some forms of
AMR are conferred by mutations in the shared core genome,
and are generally located on the bacterial chromosome. Con-
versely, other types of resistance are determined by variation
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in the composition of the accessory genome, through the
presence/absence of mobile resistance genetic elements
acquired by horizontal gene transfer (HGT).
Whole genome sequencing (WGS) allows the characteriza-
tion of the full genomic repertoire of nosocomial bacteria,
accounting for both the core and the accessory components.
Beyond its uses for strain identification and outbreak track-
ing, WGS can be used to predict phenotypic traits encoded
by non-core genes. As a result, WGS-based resistotyping
can be as accurate as, if not superior to, traditional
approaches [1–3]. Phenotype prediction from WGS is par-
ticularly relevant for traits such as AMR and virulence,
which are often encoded on conjugative plasmids that read-
ily pass between strains in circulation in hospital wards. As
a consequence, bacteria with open genomes and/or high
plasmid carriage comprise some of the most clinically chal-
lenging species worldwide [4].
Amongst the most concerning examples of multi-drug-
resistant (MDR) hospital pathogens are carbapenem-resis-
tant Klebsiella pneumoniae (CRKP) [5]. Carbapenems, such
as imipenem and meropenem, are a class of antibiotics
widely used in the treatment of severe infections caused by
Enterobacteriaceae producing extended-spectrum b-lacta-
mases (ESBLs). With few therapeutic options remaining,
CRKP infections are often associated with high levels of
morbidity and mortality [6, 7].
Carbapenem resistance in K. pneumoniae is most com-
monly mediated by the blaKPC-2 gene, which was first
identified in 1996 in the USA and is now endemic glob-
ally, with the first record in China dating back to 2004
[8–10]. blaKPC-2 is located on a Tn3-family transposon
that can insert in multiple places in the genome. blaKPC-2
can therefore be transmitted clonally via the chromosome
[11, 12], but is more commonly found on plasmids [13–
17], including those harbouring other significant AMR-
[18–20] and virulence-associated genes [21, 22]. The abil-
ity of the blaKPC-2 transposon to insert and relocate
between plasmids, across multiple enterobacterial species
[16, 23–25], suggests that the selective pressures in hospi-
tal environments create an ideal set of conditions for
highly transmissible forms of AMR [13, 16, 26–31]. Dur-
ing outbreaks, CRKP can readily spread between clinically
diagnosed infected patients, but also has the potential to
be acquired and spread via colonized medical equipment
and asymptomatic patient or staff carriers. This is particu-
larly concerning given evidence for prolonged CRKP colo-
nization in hospital settings [32].
Whilst several CRKP outbreaks have been reported in the
literature [23, 33–36], the complex drivers of transmission
and the role of plasmid and transposon dynamics in
shaping the genetic and phenotypic diversity of strains
remains challenging to resolve. This prompted us to set
up a surveillance initiative for CRKP isolates over a 14-
month period at Peking University People’s Hospital
(PKUPH), Beijing. Using the rich information provided
by WGS we investigated the full genomic diversity of
blaKPC-2 isolates in circulation, characterized the genetic
context of resistance, and reconstructed transmission
pathways within the hospital by integrating genomic and
epidemiological data.
METHODS
Data collection and description of isolates
A hospital-wide initiative was set up in February 2016 at
PKUPH to manage and characterize a CRKP outbreak. All
patients newly admitted to wards with known prevalence of
CRKP had rectal, throat or axillary swabs taken within 24 h
of their admission. Swabbing of the environment was also
performed on wards where CRKP had been detected. This
effort spanned three hospital campuses and 19 wards,
including two intensive care units (Figs S1 and S2). All
swabs, including those taken from the infection sites of
diagnosed CRKP-infected patients, were plated and
screened using China Blue Agar containing meropenem at 1
µgml 1. The presence of blaKPC was confirmed through
PCR. PCR products were visualized by agarose gel electro-
phoresis, purified with a QIAquick PCR Purification Kit
(Qiagen) and sequenced by Sanger sequencing on an ABI
PRISM 3730XL system (Applied Biosystems).
IMPACT STATEMENT
Multi-drug-resistant bacteria cause high-mortality dis-
ease outbreaks in hospitals worldwide. We set up a mon-
itoring program in a hospital in Beijing following the
death of a patient due to an infection with a Klebsiella
pneumoniae strain resistant to multiple drugs, including
to carbapenems, the last-resort antibiotics. We isolated
100 carbapenem-resistant Klebsiella pneumoniae (CRKP)
swabbed from infected patients, patient carriers and the
hospital environment over 14 months. We generated
complete genomes for all strains and reconstructed their
evolution and transmission within the hospital. The
majority of the CRKP isolates belonged to a single out-
break which started spreading at least one year before
the monitoring program began. While these bacteria had
accumulated little genetic variation on their chromo-
somes, they carried extraordinary variation in drug resis-
tance and virulence genes. We show that this diversity
was generated during the course of the outbreak through
frequent gains and losses of plasmids and exchange of
genetic material between plasmids. We also identified
cases where the number of copies of a plasmid predicted
the level of drug resistance. Our results showcase the
value of genome sequencing for investigating multi-
drug-resistant hospital outbreaks but highlight that stan-
dard bioinformatics analyses are unable to capture the
extraordinary rapid genomic evolution of CRKPs.
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All PCR-positive blaKPC-2 strains were retained for WGS
analysis. Additionally, we also included strains that were
blaKPC-2-negative as long as they had been sampled from a
patient who was also infected with a blaKPC-2-positive strain
during the surveillance period (isolates CX48 and CX106).
This resulted in a final dataset of 100 isolates collected over
a 14-month period from: (i) the infection sites of clinically
diagnosed patients who were sampled at a single time point
or sequentially through their hospital admission (n=56), (ii)
in-patient carriers identified by standard throat, nose, axil-
lary and rectal swab screens within 24 h of their admission
(n=18), (iii) patients who were positive for CRKP at both
the site of clinical infection and from surveillance screening
swabs (n=15), and (iv) from patient-associated ward envi-
ronments, including medical equipment and bed rails
(n=11) (Table S1 and Fig. S3).
Total DNA was extracted using the TIANamp Bacteria
DNA Kit DP302 (Tiangen Biotech) and stored at
 80

C. All isolates were sequenced using the Illumina
Hiseq 2500 system. Eight isolates were also later
sequenced by the PacBio RS II system (Pacific Bioscien-
ces) with a 10-kb size library and P6/C4 chemistry. All
isolates were also identified by MALDI-TOF and their
phenotypic resistance to several antibacterial agents was
determined by minimal inhibitory concentrations (MICs)
through agar or broth dilution methods (Table S2). Fol-
lowing the 14-month surveillance period, the CRKP out-
break was brought under control. This was aided by
hospital-wide interventions, including enhanced environ-
mental cleaning of CRKP-infected wards and the estab-
lishment of a new air disinfection protocol.
Reference-based whole genome alignment and
variant calling
We ran the genomic distance estimation tool Mash [37] on
trimmed and quality-filtered Illumina raw sequencing reads
to identify the best matching chromosomal reference
against an archive of complete K. pneumoniae genomes
from NCBI RefSeq. The best-matching chromosomal refer-
ence was K. pneumoniae strain SWU01 (NZ_CP018454.1).
Reads were mapped to this reference using bwa-mem
v0.7.12 [38] and SNPs were called independently for each
sample using FreeBayes v1.0.2 [39], with a minimum alter-
native fraction of 0.95 and otherwise default parameters.
Additional SNP filtering was then performed in bcftools to
extract only those SNPs with a Phred-scaled quality score of
at least 50. Regions of recombination in the resulting align-
ment were identified and excluded using ClonalFrameML
v1.11 [40]. This left a 5 057 386 bp alignment comprising
458 SNPs across the 82 closely related sequence type 11
(ST11) isolates. A maximum-likelihood phylogenetic tree
was inferred from this recombination-free chromosomal
alignment using RAxML v8.2.10 [41], implementing a GTR
model with 1000 bootstrap replicates.
Dating the start of the outbreak and the age of
lineages
Following identification of a strong temporal signal in the
82 ST11 dataset (Fig. S4), we ran BEAST v2.4.7 [42] on the
recombination-filtered chromosomal alignment to infer the
age of the outbreak as the time to the most recent common
ancestor (tMRCA). The TN93 substitution model was
selected based on evaluation of all possible substitution
models [43] and BEASTwas run under different demographic
model priors and allowing for both strict and relaxed mod-
els of the evolutionary rate (Table S3). In each case, the
Markov chain Monte Carlo (MCMC) procedure was run for
200million iterations and convergence of the chain was
inspected using Tracer v1.6.0. The maximum clade credibil-
ity (MCC) tree under each model was generated in TreeAn-
notator and plotted in ggtree [44]. The best-supported
model, evaluated through path sampling, was an exponen-
tial growth model with a strict molecular clock. However,
the results were very consistent across different specifica-
tions of the demographic model and mutation rate prior
(Table S3, Fig. S5).
Reconstruction of transmission chains
We applied TransPhylo [45] to reconstruct possible trans-
mission events between the 82 outbreak isolates. We speci-
fied a gamma distribution with a shape parameter of 1 and
a scaling parameter of 0.5 (6 months on average between
infection and transmission) as priors on the generation
time, although results were robust to variation of the scaling
parameter (Figs S6 and S7). The MCMC was run for
100 000 iterations to ensure convergence, and the consensus
posteriors were evaluated based on the probabilities of direct
transmission between any two isolates, the average number
of intermediates in the transmission chain and the number
of inferred direct links (Table S4).
We also constructed epidemiological transmission matrices
using hospital records, which provided information on
where and when patients moved through different wards
within the hospital during their admission (Fig. S2). We
constructed a ‘direct-contact’ matrix where the index of
transmission between any two patients was set to 1 if they
were present on the same ward at the same time, and 0 oth-
erwise. The agreement between the genetic transmission
matrix and the epidemiological matrix was assessed using a
Mantel test.
De novo assembly and core genome phylogenies
We also assembled our Illumina short read sequence data de
novo using SPAdes v3.10.0 [46]. The resulting assemblies
were annotated using Prokka v1.12 [47], and the core and
accessory genomes were defined and extracted using Roary
v3.11.2 [48]. Based on the core genome alignment, we con-
structed a phylogeny in RAxML v8.2.10 using a GTR model
and 1000 bootstrap replicates [41] (Figs S3, S8 and S9).
van Dorp et al., Microbial Genomics 2019;5
3
Downloaded from www.microbiologyresearch.org by
IP:  139.133.148.27
On: Fri, 05 Apr 2019 08:58:10
AMR, virulence, plasmid and transposon profiling
from WGS
De novo assemblies were screened against the ResFinder
database of published AMR genes [49]. AMR genes were
assigned using an identity threshold of 90% and a selected
minimum length of 80%. De novo assemblies were also
screened for genetic markers that have been associated with
a virulent phenotype using the Kleborate virulence predic-
tion tool [50]. Additionally, plasmid replicons diagnostic for
incompatibility groups were identified using PlasmidFinder
[51] (Tables S5-S7). The transposon structure of blaKPC-2
was elucidated through a combination of genome annota-
tion implemented in Prokka v1.12 [47], screening for inser-
tion sequences in ISFinder [52] and BLAST.
Predicting phenotypic resistance from gene
abundance
We estimated copy numbers of AMR genes by mapping our
raw Illumina short-read data to our short-read de novo con-
tig assemblies using Bowtie2 v2.2.6 [53]. The absolute num-
ber of reads that mapped to each gene [54], normalized by
gene length and sequence depth, was used to generate a
DNAseq depth of coverage, in units of transcripts per mil-
lion (TPM) [55]. We tested the correlation between our
generated pseudo-TPMs and phenotypic resistance (MICs)
for aminoglycosides (amikacin), b-lactams (meropenem
and imipenem) and quinolones (ciprofloxacin and levoflox-
acin). To account for the population structure in the cohort
of isolates analysed, we considered each lineage separately
(Figs S10–S12).
Long-read de novo assembly and evaluation
PacBio long-read sequence data from eight isolates were
assembled using multiple approaches. All strategies
employed the de novo assembly pipeline implemented by
UniCycler [56]. We ran Unicycler jointly using the long-
and short-read data to generate a hybrid assembly, as well
as also running long-read-only assemblies in both ‘normal’
and ‘bold’ modes. In addition, we ran each of these assem-
blies using the raw, unfiltered, PacBio reads, as well as fol-
lowing read quality filtering implemented in FiltLong
(https://github.com/rrwick/Filtlong). Assembly quality was
evaluated based on the number, depth and contiguity of the
assembled contigs. The choice of assembly method selected
for each isolate, together with the size and composition of
the final assemblies are provided in Table S6. We inspected
both the coverage and the percentage of the genome covered
when mapping each of our 82 ST11 short-read sequenced
isolates to each of our PacBio assemblies using bwa-mem
v0.7.12 [38] (Tables S8 and S9). We found our inferred
pseudo-TPMs correlated well with coverage of the relevant
plasmids (Fig. S13) and showed strong correlations between
genes that are known to co-occur (e.g. Fig. S10a), suggesting
they provide a reliable proxy for copy number. We also eval-
uated the percentage identity between different assembled
plasmids (Fig. S14) and annotated long-read assembled con-
tigs to further elucidate the blaKPC-2 transposon structure
(Fig. S15).
RESULTS
General features of the outbreak
Following the death of a patient at PKUPH caused by a
CRKP bloodstream infection in February 2016 (Patient X),
a surveillance initiative was instigated to stem the subse-
quent outbreak and assess the presence of CRKP through-
out the hospital over a 14-month period. This resulted in
the identification of 100 CRKP isolates sampled from 19
wards spread over three hospital campuses, which included
two intensive care unit (ICU) wards (Figs S1 and S2).
WGS data and phenotypic resistance profiles (MICs) were
generated for all 100 CRKP isolates (Tables S1 and S2).
These isolates grouped into 11 STs, of which 83/100 isolates
were assigned to ST11, the dominant CRKP clone in China
[23, 57] (Fig. S3). We excluded one ST11 isolate (CX3) that
was a clear phylogenetic outgroup, and therefore not part of
the identified outbreak. Phylogenetic analyses resolved the
remaining 82 isolates into three closely related lineages (we
refer to these as Lineages 1, 2 and 3) together with seven iso-
lates falling outside of these main lineages (Fig. 1a). There
was no obvious association between campus or ward of iso-
lation and the inferred phylogenetic relationships (Fig. S8).
One patient (Patient 29) was co-infected, with a single Line-
age 1 isolate (CX102), and seven Lineage 2 isolates, includ-
ing one isolate that was also detected from swabbing the
patient’s bed table (Fig. 1a).
We found a strong temporal signal in the accumulation of
mutations on the non-recombining fraction of the chromo-
somal sequence alignment (Fig. S4), justifying the use of tip-
dating phylogenetic calibration [58]. Bayesian approaches
to infer the tMRCA pointed to these isolates sharing a com-
mon ancestor in 2013 (2013.9; 95% HPD, 2013.2–2014.4),
based on an inferred evolutionary clock-rate of 3.410 6
(2.710 6 to 4.210 6) substitutions per site per year
(Fig. 1a, Table S3 and Fig. S5). This inferred age pre-dates
the admission of Patient X (previously considered the
‘index’ patient) by over 1 year. As such, these CRKP strains
were in circulation in the hospital for around 2 years prior
to initiation of the hospital-wide CRKP surveillance initia-
tive, which only commenced after the death of Patient X.
High transmissibility across wards and campuses
We identified 34 plausible direct links between pairs of
ST11 isolates during the outbreak (Figs 1b, S6 and S7 and
Table S4). Excluding links inferred from isolates sampled
from the same patient, 25 direct transmissions were identi-
fied between patients, including seven within the same
ward, and 18 between isolates sampled across different
wards within the hospital. None of these between-patient
transmissions involved either of the two isolates sampled
from Patient X. Six of the between-patient transmission
events occurred across hospital campuses A and B, which
were located 14 km apart (Fig. S1). In our dataset, only two
patients were directly transferred between campus A and B
during their admissions (Patients 12 and 29). Isolates from
these patients were involved in only two of the six cross-
van Dorp et al., Microbial Genomics 2019;5
4
Downloaded from www.microbiologyresearch.org by
IP:  139.133.148.27
On: Fri, 05 Apr 2019 08:58:10
campus transmissions, suggesting a possible additional role
of CRKP transfer mediated by the movement of staff or
equipment.
Among the 25 direct transmissions, there were 21 instances
involving at least one isolate sampled directly from one of
two ICU wards. In ten of these cases, the patients involved
in the direct transmission pair had overlapping admissions,
which we consider as ‘direct-contacts’. In a further four
cases patients were admitted to the same ICU ward within 2
weeks of each other. We found some correspondence
between the transmission events inferred from the genomic
data and those inferred solely from epidemiological data.
There was a moderate, but statistically highly significant
correlation between the matrix of transmission events
inferred from the genomic data and the epidemiological
‘direct-contact’ events (R=0.147; P<0.001; Mantel test).
Diversity in AMR gene carriage and phenotypic
resistance
The three-lineage structure was well supported by a pan-
genome phylogeny (Figs 2 and S8). Despite limited variation
in the core genome, we noted considerable variability in the
accessory component (Fig. S9). All 82 related CRKP isolates
were highly drug resistant, harbouring elements conferring
resistance to aminoglycosides, b-lactams, fosfomycin, qui-
nolones and sulphonamides, but with considerable variation
in the resistance-conferring elements carried. Indeed, only
one assigned resistance gene, fosA, was present in all 82 iso-
lates (Fig. 2).
We identified diversity in the AMR gene component both
between and within lineages. For example, CX45 in Lineage
3 carried additional resistance elements for aminoglycosides
not observed in any other isolates (dfrA17 and aadA5)
together with resistance elements unique to its lineage,
including tetA, mphA, strA, strB and aac[3]-IId. As well as
gains, we also identified cases of AMR gene loss. For exam-
ple, isolates CX103 and CX104 were unique among Lineage
2 isolates in not carrying the rmtB (aminoglycoside resis-
tance) gene and blaTEM-1B. We also identified two cases of
secondary loss of blaKPC-2 in CX48 and CX106 (Figs 1a and
2). Although these may represent losses in culture, they
could also plausibly represent genuine secondary losses in
patients.
As well as AMR gene presence and absence, CRKP isolates
showed considerable variation in phenotypic resistance to
Fig. 1. Dated phylogeny and inferred direct transmission events across outbreak isolates. (a) Dated phylogeny of the recombination-
free chromosomal alignment of 82 ST11 outbreak isolates. Grey bars give the inferred 95% highest posterior density (HPD) interval
around node heights. Tips are coloured according to the infection status and isolate source. The tip symbols of two isolates are
marked with an asterisk denoting the absence of blaKPC-2. The vertical dotted line provides the date the ‘index’ patient (Patient X) was
first admitted. Lineages are defined as 1, 2 and 3 with seven outlying isolates. (b) Direct transmission events inferred by TransPhylo
between 82 ST11 isolates. The inner ring provides the ward of isolation (either common or intensive care), while the outer ring pro-
vides the hospital campus (A, B, C), as coloured in the legends. We infer 14 direct transmissions within Lineage 3, 10 within Lineage 2
and nine within Lineage 1, with one transmission inferred between CX90 and CX91 isolated from the same patient (Patient X) 1 day
apart. Isolates marked with a circle on the outer ring are from Patient 29 who was co-infected with CRKP+ strains from two lineages
and was one of two sampled patients who spent time on both Campus A and Campus B during their admission. Isolates marked with a
triangle were sampled from the first ‘index’ patient identified as positive for blaKPC-2, Patient X.
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different drug classes (Table S2). Isolates from closely
related lineages often had different resistance mechanisms
present, including mobile genes associated with the acces-
sory genome. Resistance gene abundances, as measured
through pseudo-TPMs (see Methods), could in some cases
be quantitatively associated with AMR phenotype, mea-
sured by MICs. We identified lineages with a significant cor-
relation between gene abundance and resistance phenotype
response for aminoglycosides (Fig. S10), b-lactams (Fig.
S11) and quinolones (Fig. S12). This suggests that gene copy
number variation, for example mediated through the car-
riage of multiple plasmids carrying the same AMR gene,
beyond simple presence and absence, may contribute to
AMR phenotypes in a quantitatively predictive way.
Diversity in virulence genes
We screened for genes associated with increased pathoge-
nicity [50]. All isolates carried the yersiniabactin sidero-
phore (type ybt9) on an integrative conjugative element
(ICEKp3), suggesting a common mechanism for acquiring
iron to support growth in host tissues (Fig. 2). Three isolates
also carried the acquired aerobactin siderophore gene (iuc),
which is involved in scavenging iron from host blood
transferrin [59] and is a commonly used genetic marker of
virulence. Two of these isolates were from Patient X (CX90,
CX91) and one was from Patient 55 (CX45). CX90 and
CX91 also carried the genes rmpA and rmpA2, which are
associated with both virulence and a hypermucoviscous
phenotype [50, 60, 61]. While Patient X died as a result of
CRKP infection, Patient 55 recovered and was discharged.
Diversity in plasmid carriage
We assigned plasmid incompatibility groups to explore car-
riage of the identified AMR and virulence determinants.
Plasmid carriage was high, with 3.74 (mean) unique match-
ing plasmid replicons identified per isolate. Amongst these,
all isolates showed evidence of carrying an IncFII-like plas-
mid, with all but one (CX68) also carrying an ~10 060 bp
(ColRNAI) plasmid (Table S5). Lineage 1 and Lineage 2 iso-
lates carried on average more plasmids (based on identified
replicons) than Lineage 3 (mean per isolate: 4.84, 4.22, 2.22,
respectively). Despite the homology of the chromosomes of
Lineage 2 and Lineage 3 (pairwise SNP difference across lin-
eages of 42–57 (95% confidence interval [CI], Fig. S4a),
their plasmid carriage was strikingly different.
Fig. 2. Core genome phylogeny, AMR and virulence profiles. (a) Core genome phylogeny of 82 ST11 outbreak isolates with the three-
lineage structure highlighted in colour, as in Fig. 1. The three tip points marked with an asterisk (*) identify those isolates assigned as
hypervirulent based on the presence of the genes rmpA, rmpA2 and/or the iuc operon. (b) Antimicrobial resistance gene complement
and inferred virulence profiles of the 82 ST11 outbreak isolates shown in (a). Coloured squares give the presence of AMR genes and
genetic markers associated with virulence, with the colour of AMR gene presence providing the antibiotic drug class to which resis-
tance is conferred, as given in the legend to the right.
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We explored the accessory genomes of CRKP isolates fur-
ther using long-read sequencing assemblies of eight isolates
from the outbreak cohort (Tables S6 and S7, Fig. 3). Consis-
tent with our assignments based on identified plasmid repli-
cons, Lineage 3 assemblies carried one fewer plasmid.
Although short-read assemblies and genetic markers of
resistance and virulence suggested the presence of an addi-
tional plasmid carried uniquely in Lineage 3 (isolate CX45),
we were unable to identify this using long-read sequencing,
suggesting this plasmid may have been lost in the culture
for long-read sequencing of isolate CX45 (Fig. 3).
Long-read assemblies allowed us to observe multiple gains
and losses of plasmids, leading to extensive variations in
plasmid component and copy number across the 82 ST11
isolates (Fig. 3, Tables S6, S8 and S9). For example, the
ColRNAI plasmid was often present at high copy relative to
the chromosome (0.94–11.97 95%CI). We also noted dif-
ferences in coverage of the blaKPC-2-carrying plasmid, with
Lineage 2 isolates tending to carry blaKPC-2 plasmids at
higher copy number (Table S8). This is in good agreement
with our analysis of the correlation between b-lactam gene
copy number and quantitative phenotypic resistance, which
identified blaKPC-2 as a key driver of b-lactam resistance in
Lineage 2 (Fig. S11b,c). We also identified at least one
instance of large genomic regions shared between plasmids,
consistent with putative recombination between them
(Fig. S14).
Isolate CX90 from Patient X had an additional large IncFIB
(Mar) blaOXA-1-positive (284 904 bp) plasmid which had
high sequence similarity to a previously sequenced
288 222 bp virulence plasmid isolated from a human host at
Chengdu, Sichuan, in July 2016 (CP028791.1). As well as
carrying AMR genes involved in fluoroquinolone and ami-
noglycoside resistance (aac(6’)Ib-cr), phenicol resistance
(catB3), rifampicin resistance (arr-3) and sulphonamide
resistance (sul1), this plasmid carried the previously identi-
fied rmpA and rmpA2 markers of hypermucovisity and
iucABCD operon involved in aerobactin synthesis (Fig. 2).
This plasmid was absent from all isolates other than those
from Patient X. Because these two highly related isolates
Fig. 3. Diversity in plasmid type and carriage across eight isolates involved in the outbreak. Complement of plasmids carried by eight
isolates assembled using PacBio long-read technology, sampled over the time-course of the outbreak. The colour provides the Inc type
assignment of the plasmids based on the presence of plasmid replicon sequences and is given in the legend at the bottom. Plasmid
copy number relative to coverage over the chromosome is provided to the right of each depicted plasmid. blaKPC-2-carrying plasmids
are denoted with the triangular symbol and are found in the third column. Virulence plasmids are defined as those carrying the rmpA,
rmpA2 and/or iuc operon genes. We have also included the virulence plasmid of CX45 (in grey), which we were able to identify from
short-read sequencing. The phylogeny on the left provides the core genome phylogeny for these eight isolates, with chromosomal Lin-
eages 1–3 highlighted in colour, as in Figs 1 and 2.
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were not involved in further transmissions to other patients
(Fig. 1a), it is likely that this plasmid was acquired de novo
by the strain infecting Patient X (Fig. 4, Tables S8 and S9).
High mobility of blaKPC-2
blaKPC-2 was found on 80 conserved contigs in the ST11
outbreak cohort, ranging in size from 2393 to 9266 bp. All
blaKPC-2 were found on TN1722-based isoforms with a
transposon structure of type DISKpn6-KPC-2-DISKpn27-D
TnpR (Fig. S15) and contained two promoters associated
with the blaKPC-2 transcription start sites: the intrinsic pro-
moter P1 and the upstream promoter P2 [62].
Notably, based on our long-read assemblies, blaKPC-2 was
found on a variety of different IncF plasmid backgrounds:
IncFII (n=4), IncFII also carrying an IncR-associated repli-
con (n=1), IncFIA (n=1), IncFIB(K) (n=1) and IncFIB(K)
with an IncFII-associated replicon (n=1) (Fig. 3, Table S7,
Fig. S15). The diversity of blaKPC-2 plasmid backgrounds is
best explained by frequent transpositions and acquisitions
of blaKPC-2 between plasmids during the course of the
outbreak.
DISCUSSION
In this work we identified an outbreak of 82 closely related
ST11 blaKPC-2-positive isolates during a 14-month surveil-
lance initiative at a Beijing hospital. Using WGS analyses,
we show that these isolates had been in circulation for at
least 1 year prior to the initiation of our sampling efforts
and had accumulated extensive genetic and phenotypic
diversity that cannot be captured by commonly used typing
schemes which rely on variation on the chromosome.
The application of WGS allowed us to gain deeper insight
into the extensive transmission of these isolates between
patients. For example, the patient initially suspected to be
the index case (Patient X) was probably not involved in any
subsequent transmission to other patients. Interestingly, the
two CRKP samples isolated from Patient X were unique in
their carriage of a blaOXA-1 virulence plasmid, probably
acquired by the infecting strain, which may have contrib-
uted to the fatal outcome of this patient.
Our reconstruction of transmission events during the out-
break suggested that ICUs were a key environment for
direct patient-to-patient transmission. Whilst in many
instances these transmissions correlated well with the
Fig. 4. Coverage of outbreak isolates to the CX90 assembly highlights variation in plasmid carriage and copy number. Mean coverage
per isolate of 82 short-read sequenced ST11 K. pneumoniae mapped to the complete genome of CX90 (red tip point), sampled from the
‘index’ patient, Patient X, and sequenced using long-read technology. The phylogeny to the left provides the chromosomally dated phy-
logeny of 82 outbreak isolates, with the lineage structure highlighted in colour, as in Figs 1–3. The bar plots provide the mean cover-
age relative to the chromosome for each plasmid. Any isolates with a mean coverage relative to the chromosome <0.1 are not
shown.
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movement of patients through the hospital based on admis-
sion records, we also inferred transmissions within our
dataset (e.g. across hospital campuses) which could not be
predicted by the epidemiological data alone. This suggests a
possible role of the movement of staff, equipment or further
unsampled sources in the transmission of nosocomial
pathogens, as well as highlighting the need to integrate both
genetic and epidemiological data to fully track and recon-
struct outbreaks.
Despite all 82 isolates having closely related chromosomes
(a mean of 58 pairwise SNP differences across all lineages;
95%CI 8–96 SNPs), we identified marked accessory
genome diversity, including variation in resistance genes,
virulence-associated genes and plasmid carriage. For exam-
ple, we were able to identify a plasmid carried uniquely in a
single patient, between-plasmid recombination events and
transposon-mediated exchange of the blaKPC-2 gene.
Remarkably, only a single recognized AMR gene was pres-
ent in all 82 isolates (fosA). This highlights how plasticity in
the accessory genome occurs even at small geographical and
temporal scales. We also identified examples where plasmid
copy number variation correlated with quantitative AMR
phenotypes, indicating that the relative abundance and sta-
bility of AMR-carrying plasmids may be an important and
largely uncharacterized contributor to levels of phenotypic
resistance in hospital strains. Exploring the nature of this
relationship in other closely related drug-resistant lineages,
and for other antibiotic classes, is an important area of
future work.
High mobility of blaKPC elements has been previously docu-
mented in a Tn4401b blaKPC-carrying cohort from a tertiary
care hospital in Virginia, USA [16], and during long-term
colonization of a patient in the USA [32]. The analysis of
this outbreak further confirms the extraordinary potential
for mobility of blaKPC-2-carrying transposons. Indeed, the
blaKPC-2 element was found on four different plasmid back-
grounds in the eight outbreak strains that were sequenced
with long reads. Intriguingly, given the extraordinary rate of
transposition of the blaKPC-2-carrying transposon and the
rapid turnover of the plasmid complement, we did not iden-
tify a single outbreak strain carrying more than one copy of
blaKPC-2.
Our findings further confirm that CRKP represents a signif-
icant AMR threat [5] requiring increased global study and
surveillance. The fast genotypic evolution that we describe
in K. pneumoniae lineages, through multiple gains, losses
and rearrangement of the accessory genome, probably
allows this nosocomial pathogen to rapidly adapt to essen-
tially any antibiotic used in treatment over very short peri-
ods of time.
The use of WGS is becoming widespread in clinical micro-
biology, but analysis often relies on reference-based map-
ping, which focuses on genetic variation on the
chromosome, which remained relatively conserved in these
outbreak lineages and did not well recapitulate either the
dynamics of the accessory genome or the resistance pheno-
type. This highlights the need for better WGS-based diag-
nostics tools which incorporate plasmid characterization,
such as resistance gene copy number variation, to tackle the
growing incidence of multi-drug-resistant nosocomial infec-
tions and provide patients with the best care possible in the
future.
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